SCHEMBL25818437

SCHEMBL25818437

Clc1nc(-c2cccc(-c3ccc4cc(-c5cccc6ccccc56)ccc4c3)c2)nc(-c2cccc3oc4ccccc4c23)n1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.38
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 4/20 0.38
ATM Q13315 2/20 0.38
CYP1A2 P05177 1/20 0.38
CYP2C19 P33261 1/20 0.38
RAB9A P51151 1/20 0.38
MAPT P10636 4/20 0.35
HPGD P15428 3/20 0.34
TDP1 Q9NUW8 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
TSHR P16473 2/20 0.34
TP53 P04637 1/20 0.34
NFKB1 P19838 1/20 0.34
MAPK1 P28482 1/20 0.34
NFKB2 Q00653 1/20 0.34
RELA Q04206 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
CA12 O43570 1/20 0.34
CA1 P00915 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25818467 0.97 ALDH1A1 (0.37) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL25818489 0.94 BACE1 (0.36) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL22274543 0.94 BACE1 (0.36) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL25817804 0.94 ALDH1A1 (0.38) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL22161407 0.94 ALDH1A1 (0.39) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL25817718 0.92 ALDH1A1 (0.42) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL25818422 0.92 PLA2G2A (0.38) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL24657325 0.92 ALDH1A1 (0.40) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL25818522 0.91 HSD17B1 (0.36) ALDH1A1KDM4EHSD17B10ATMCYP1A2
SCHEMBL23819720 0.91 PIM1 (0.36) ALDH1A1KDM4EHSD17B10ATMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof DUK SAN NEOLUX CO., LTD. (KR) 2024-02-27 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF DUK SAN NEOLUX CO., LTD. (KR) 2023-07-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11917914-B1 Compound for organic electronic element, organic electronic element using the same, and an electronic device thereof NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885KDM4E 508/4885HSD17B10 3433/4885
US-20230225206-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF NFE2L2, ESR1, OR51E2 ALDH1A1 1010/4885KDM4E 508/4885HSD17B10 3433/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.